ERWM
TMO icon

Elk River Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Elk River Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.08M Sell
8,135
-870
-10% -$418K 0.65% 38
2026
Q1 		$4.43M Sell
9,005
-39
-0.4% -$21.2K 0.74% 37
2025
Q4 		$5.24M Sell
9,044
-301
-3% -$170K 0.84% 33
2025
Q3 		$4.54M Sell
9,345
-152
-2% -$70.8K 0.73% 38
2025
Q2 		$3.85M Sell
9,497
-241
-2% -$101K 0.66% 41
2025
Q1 		$4.85M Sell
9,738
-121
-1% -$65.5K 0.91% 34
2024
Q4 		$5.13M Sell
9,859
-38
-0.4% -$20.9K 0.93% 32
2024
Q3 		$6.13M Buy
9,897
+100
+1% +$59.2K 1.11% 29
2024
Q2 		$5.42M Buy
9,797
+71
+0.7% +$40.7K 1.06% 32
2024
Q1 		$5.66M Sell
9,726
-1,036
-10% -$581K 1.15% 28
2023
Q4 		$5.72M Buy
10,762
+71
+0.7% +$34.4K 1.1% 29
2023
Q3 		$5.42M Buy
10,691
+95
+0.9% +$50.6K 1.2% 28
2023
Q2 		$5.53M Sell
10,596
-127
-1% -$68.5K 1.18% 28
2023
Q1 		$6.18M Buy
10,723
+315
+3% +$178K 1.4% 25
2022
Q4 		$5.73M Buy
10,408
+50
+0.5% +$26.5K 1.39% 25
2022
Q3 		$5.26M Buy
10,358
+329
+3% +$184K 1.39% 24
2022
Q2 		$5.45M Buy
10,029
+163
+2% +$89.7K 1.38% 23
2022
Q1 		$5.83M Buy
9,866
+618
+7% +$355K 1.27% 23
2021
Q4 		$6.17M Buy
9,248
+85
+0.9% +$53.1K 1.4% 22
2021
Q3 		$5.24M Buy
9,163
+222
+2% +$122K 1.32% 24
2021
Q2 		$4.51M Buy
8,941
+161
+2% +$76K 1.17% 29
2021
Q1 		$4.01M Buy
8,780
+819
+10% +$391K 1.14% 29
2020
Q4 		$3.71M Buy
+7,961
New +$3.73M 1.23% 29

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Elk River Wealth Management's TMO Position: Q2 2026 in Review

Elk River Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 9.7% in Q2 2026, selling an estimated $418K and leaving 8,135 shares worth $4.08M. The position accounts for 0.65% of the portfolio, ranked #38.

Elk River Wealth Management first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $6.18M in Q1 2023. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Elk River Wealth Management held 8,135 shares of Thermo Fisher Scientific worth $4.08M as of Q2 2026.
  • Elk River Wealth Management sold 870 Thermo Fisher Scientific shares in Q2 2026, an estimated $418K.
  • Thermo Fisher Scientific made up 0.65% of Elk River Wealth Management's portfolio in Q2 2026, its #38 holding.
  • Elk River Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • Elk River Wealth Management's Thermo Fisher Scientific position peaked at $6.18M in Q1 2023.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Elk River Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.